undefined

Carl Kawaja

Portfolio manager at Capital Group, overseeing a large portfolio for decades. Known for his insightful perspectives on market regimes and investment strategies.

Top 3 podcasts with Carl Kawaja

Ranked by the Snipd community
undefined
241 snips
Jan 31, 2023 • 1h 13min

Carl Kawaja - Dealing with Regime Change - [Invest Like the Best, EP.314]

Carl Kawaja, a seasoned portfolio manager at Capital Group, shares his deep insights on the changing landscape of capital markets. He discusses the impact of rising capital costs and industry layoffs while emphasizing the importance of adaptability in investment strategies. Intriguingly, he draws parallels between Muhammad Ali’s boxing ring tactics and the need for flexible approaches in investing. Kawaja also explores unique perspectives from the Amazonian Piraha tribe and shares lessons from a transformative Norwegian CEO, illustrating innovation in diverse fields.
undefined
5 snips
Jul 27, 2021 • 1h 30min

Carl Kawaja - Wisdom from Decades of Investing - [Invest Like the Best, EP. 236]

Carl Kawaja, a seasoned portfolio manager at Capital Group, shares decades of wisdom on long-term investing. He discusses his criteria for building conviction in volatile markets and reframes uncertainty as a healthy aspect of investing. Carl highlights personal investment experiences with TSMC and Vale, illustrating how unique resources create competitive advantages. With engaging metaphors like river rafting, he emphasizes resilience and adaptability in navigating the ever-changing investment landscape. His insights make a compelling case for embracing failure as part of the journey.
undefined
4 snips
Aug 15, 2024 • 16min

The heavy impact of weight loss drugs

Carl Kawaja, a portfolio manager at Capital Group, offers a deep dive into the rising trend of weight loss drugs like Ozempic and Wegovy. He discusses their revolutionary effects on appetite, consumer habits, and the food industry, including surprising impacts on cravings for unhealthy products. The podcast also touches on the healthcare implications, highlighting how these medications can reduce obesity-related diseases and even modify behaviors around alcohol and cigarettes. It's a fascinating exploration of innovation reshaping health and markets.